Closed transaction
- Advised by
- Deal stage
- Closed transaction
- Service
- Equity
- Sector
- Healthcare
- Sub-sector
- Other Healthcare
- Market
- Asia
Deal details
Raise $1Million to fund growth for a diabetes health management system.
Type 2 Diabetes reversal and management health system. Capital is required to build distribution and scale and create an AI based health service (currently online and in person offering). Transaction could be a merger into a primary health group or alternatively equity raise. IP is transferable to other countries. Independent scientific research confirmed patient results of:
- 60% reversed their type 2 diabetes
- 9kg weight loss maintained after 6 months
- 75% reduced or eliminated medications for managing diabetes
- All enjoyed sustained weight loss, improved glucose levels, and a revitalised attitude towards life.
Deal team
01Members / select to view profile
Lindley Edwards
RolePartner
FirmAFG Venture Group
Lindley Edwards is a specialist adviser in merger, acquisition, divestments, fund raising, strategic consulting and licensing for growth public and private companies.
View profile
AFG Venture Group latest deals
Equity advisory
Setmetrics provides engineering grade modelling tool to allow commercial and industrial built environment owners to improve facility and energy management efficiency.
- Adviser
- AFG Venture Group
- Where
- Australia
- Year
- 2023
Equity advisory
Raise Pre IPO $1.2 Million capital for a sustainable Electric Vehicle Charging Stations company, which is aggregating carwash business and adding rapid charging capacity.
- Adviser
- AFG Venture Group
- Where
- Australia
- Year
- 2023
Equity advisory
Raise AUD $1Million: AI coaching for professional & personal development platform for individuals & teams.
- Adviser
- AFG Venture Group
- Where
- Australia
- Year
- 2023
Equity advisory
Raising convertible notes $10Million to restart an Australian Gold Mine.
- Adviser
- AFG Venture Group
- Where
- Australia
- Year
- 2023
More deals in Healthcare
Sell-side advisory
NUTRIBRAIN was sold to LABORATORIOS RUBIÓ.
- Adviser
- INEO Corporate
- Where
- Spain
- Year
- 2026
Sell-side advisory
PharmaX Solutions was sold to BioPhorum.
- Adviser
- Hoffmann & Partner
- Where
- Switzerland
- Year
- 2026
Sell-side advisory
Nostos Genomics was sold to Limbus Medical Technologies (varvis®).
- Adviser
- Hoffmann & Partner
- Where
- Switzerland
- Year
- 2025
Sell-side advisory
3iM Healthcare AB acquired Avia Pharma.
- Adviser
- Evli Corporate Finance AB
- Where
- Finland
- Year
- 2025
Membership
Gain worldwide reach with CapFive M&A professionals
The professionals of CapFive have been carefully selected on the basis of reputation, relationships, proven track record and knowledge of local markets.
Become a member